Latest News

Rhythm announces first study site for trial of new colorectal cancer diagnostic February 21, 2019

Rhythm Biosciences (ASX:RHY) has announced that Adelaide’s Lyell McEwin Hospital will be the first study site for the 1,000-patient prospective clinical trial of its blood test, ColoSTAT, for the early detection of colorectal cancer.

Melbourne-based company updates on pain trial February 21, 2019

Melbourne-based company Medical Ethics has announced the first patient has been successfully treated in its Phase 2a study of Tri-Solfen and Medi-Solfen.

First equity raise for hearing solutions company Hemideina February 20, 2019

Hemideina, a hearing solutions company focussed on the development and commercialisation of the Hera Wireless Implant, has successfully raised a Series A investment of $1 million in their first round of equity financing.

Fate of R&D tax reform a matter for election winner February 20, 2019

The fate of the federal government's proposed reforms to cut spending on the R&D Tax Incentive is unlikely to be resolved before the election.

Bionomics updates on additional data analysis of BNC210 for PTSD February 19, 2019

Adelaide-based clinical-stage biopharmaceutical company Bionomics (ASX:BNO) has announced the details of an additional data analysis of a phase 2 trial of BNC210 that shows a statistically significant response in the treatment of PTSD symptoms.

Partnership to manage Biomedical Translation Bridge Program February 19, 2019

The federal government has announced that a partnership between BioCurate, MTPConnect, UniQuest and the Medical Device Partnering Program, will operate the $22.3 million Biomedical Translation Bridge (BTB) Program.

New products drive Cochlear growth February 19, 2019

The company said the highlight was the services business that grew revenue by 28 per cent with sound processor upgrade revenue increasing by 26 per cent in constant currency terms.

Creso confirms new Canadian license for subsidiary February 19, 2019

Creso Pharma (ASX:CPH) has announced that wholly-owned subsidiary, Mernova Medical, has been granted a license to cultivate by Health Canada.

Strong result for CSL February 14, 2019

A strong first half for CSL with Australia's leading life sciences company reporting a 7 per cent jump in net profit on the back of an 11 per cent increase in revenue to $4.505 billion.

Nominations open for 2019 Victorian Manufacturing Hall of Fame Awards February 14, 2019

This year’s awards, adopting the theme of ‘Industrial Evolution’, are designed to recognise innovative and entrepreneurial local businesses and individuals that have made outstanding contributions to Victorian manufacturing.

Minomic announces new US agreement for MiCheck February 14, 2019

Australian diagnostic company Minomic International has announced an agreement with Cirrus Dx, a CLIA Certified 'High Complexity' Laboratory, enabling US clinicians and patients early access to the company’s novel test for Prostate Cancer.

Orthocell releases results from 2018 Annual Quality Study February 14, 2019

According to managing director Paul Anderson, “We are delighted by these results which provide strong evidence that Ortho-ATI is a breakthrough technology and significantly improves patients’ lives."

Most Read

Rhythm announces first study site for trial of new colorectal cancer diagnostic

Boosting Australia at BioKorea 2019

Melbourne-based company updates on pain trial

New Stories

Rhythm announces first study site for trial of new colorectal cancer diagnostic

Melbourne-based company updates on pain trial

Boosting Australia at BioKorea 2019

First equity raise for hearing solutions company Hemideina

Fate of R&D tax reform a matter for election winner

Bionomics updates on additional data analysis of BNC210 for PTSD

Partnership to manage Biomedical Translation Bridge Program

Sign In

Most Read

Rhythm announces first study site for trial of new colorectal cancer diagnostic

Boosting Australia at BioKorea 2019

Melbourne-based company updates on pain trial

Follow Us

New Stories

Rhythm announces first study site for trial of new colorectal cancer diagnostic

Melbourne-based company updates on pain trial

Boosting Australia at BioKorea 2019

First equity raise for hearing solutions company Hemideina

Fate of R&D tax reform a matter for election winner

Bionomics updates on additional data analysis of BNC210 for PTSD

Partnership to manage Biomedical Translation Bridge Program